A Phase II Study of Gemcitabine, Vincristine, and Cisplatin (Gvp) As Second-Line Treatment for Patients with Advanced Soft Tissue Sarcoma

Patients with advanced soft tissue sarcoma (aSTS) typically have a poor prognosis. Patients progressing to doxorubicin-based regimen have limited therapeutic options. Monotherapy with cytotoxic drugs appears to have only modest activity in the second-line setting. The purpose of this phase II study...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhiguo, Zhang, Xiaowei, Peng, Wei, Wu, Xianghua, Wang, Huijie, Yu, Hui, Wang, Jialei, Chang, Jianhua, Hong, Xiaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985388/
https://www.ncbi.nlm.nih.gov/pubmed/26512574
http://dx.doi.org/10.1097/MD.0000000000001777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985388/
https://www.ncbi.nlm.nih.gov/pubmed/26512574
http://dx.doi.org/10.1097/MD.0000000000001777

Ejemplares similares